Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × anlotinib × Clear all

NCT07025174 2025-06-17

SAIB

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT04300959 2020-03-09

Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms